ARS:年度报告
04/25 16:42 (美东)
DEFA14A:其他
04/25 16:41 (美东)
DEF 14A:股东委托书决议
04/25 16:38 (美东)
Revolution Medicines | 4:持股变动声明-高管 GOLDSMITH MARK A
04/12 20:13 (美东)
Revolution Medicines | 4:持股变动声明-董事 Patel Sushil
04/12 16:28 (美东)
Revolution Medicines | 144:拟议出售证券
04/10 16:24 (美东)
Revolution Medicines | 144:拟议出售证券
04/10 16:24 (美东)
Revolution Medicines | 144:拟议出售证券
04/10 16:24 (美东)
Revolution Medicines | 144:拟议出售证券
04/10 16:24 (美东)
Revolution Medicines | 3:首次持股声明-高管 Wei Lin
03/29 16:58 (美东)
Revolution Medicines | 4:持股变动声明-高管 Cislini Jeff
03/28 16:18 (美东)
Revolution Medicines | 144:拟议出售证券
03/27 16:30 (美东)
Revolution Medicines | 4:持股变动声明-高管 Kelsey Stephen Michael
03/20 16:49 (美东)
Revolution Medicines | 4:持股变动声明-高管 Cislini Jeff
03/20 16:49 (美东)
Revolution Medicines | 4:持股变动声明-高管 Horn Margaret A
03/20 16:48 (美东)
Revolution Medicines | 4:持股变动声明-高管 GOLDSMITH MARK A
03/20 16:48 (美东)
Revolution Medicines | 4:持股变动声明-高管 Anders Jack
03/20 16:48 (美东)
Revolution Medicines | 144:拟议出售证券
03/15 17:52 (美东)
Revolution Medicines | 144:拟议出售证券
03/15 17:27 (美东)
Revolution Medicines | 144:拟议出售证券
03/15 17:17 (美东)
暂无数据
暂无数据